Journal
New England Journal of Medicine
Publication Date
1-5-2023
Volume
388
Issue
1
First Page
9
Last Page
21
Document Type
Open Access Publication
DOI
10.1056/NEJMoa2212948
Rights and Permissions
van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S, Froelich L, Katayama S, Sabbagh M, Vellas B, Watson D, Dhadda S, Irizarry M, Kramer LD, Iwatsubo T. Lecanemab in Early Alzheimer's Disease. N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Copyright © 2023 Massachusetts Medical Society. Reprinted with permission.
Recommended Citation
van Dyck, Christopher H; Bateman, Randall J; and et al., "Lecanemab in early Alzheimer's disease." New England Journal of Medicine. 388, 1. 9 - 21. (2023).
https://digitalcommons.wustl.edu/oa_4/2191
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
